M. Hallak Et Al. , "Comparison of disease-modifying anti-rheumatic drugs and hyperbaric oxygen therapy in the experimental model of rheumatoid arthritis in rats," Clinical and Experimental Pharmacology and Physiology , vol.51, no.8, 2024
Hallak, M. Et Al. 2024. Comparison of disease-modifying anti-rheumatic drugs and hyperbaric oxygen therapy in the experimental model of rheumatoid arthritis in rats. Clinical and Experimental Pharmacology and Physiology , vol.51, no.8 .
Hallak, M., İNAL, A., BAKTIR, M. A., & ATASEVER, A., (2024). Comparison of disease-modifying anti-rheumatic drugs and hyperbaric oxygen therapy in the experimental model of rheumatoid arthritis in rats. Clinical and Experimental Pharmacology and Physiology , vol.51, no.8.
Hallak, Mohamad Et Al. "Comparison of disease-modifying anti-rheumatic drugs and hyperbaric oxygen therapy in the experimental model of rheumatoid arthritis in rats," Clinical and Experimental Pharmacology and Physiology , vol.51, no.8, 2024
Hallak, Mohamad Et Al. "Comparison of disease-modifying anti-rheumatic drugs and hyperbaric oxygen therapy in the experimental model of rheumatoid arthritis in rats." Clinical and Experimental Pharmacology and Physiology , vol.51, no.8, 2024
Hallak, M. Et Al. (2024) . "Comparison of disease-modifying anti-rheumatic drugs and hyperbaric oxygen therapy in the experimental model of rheumatoid arthritis in rats." Clinical and Experimental Pharmacology and Physiology , vol.51, no.8.
@article{article, author={Mohamad Hallak Et Al. }, title={Comparison of disease-modifying anti-rheumatic drugs and hyperbaric oxygen therapy in the experimental model of rheumatoid arthritis in rats}, journal={Clinical and Experimental Pharmacology and Physiology}, year=2024}